Clinical Trial Update: Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for enzalutamide with leuprolide ± abiraterone/pred in prostate cancer; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-risk Prostate Cancer
• Prostate Adenocarcinoma
• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)
• Enzalutamide (enzalutamide)
• Leuprolide (Leuprolide acetate)
• pred (prednisone)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Prostate Adenocarcinoma, Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-10-08